tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastilised ained - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
lubion süstelahus
ibsa farmaceutici italia s.r.l. - progesteroon - süstelahus - 25mg 1tk; 25mg 7tk
meriofert set süstelahuse pulber ja lahusti
ibsa farmaceutici italia s.r.l. - menopausaalne humaangonadotropiin - süstelahuse pulber ja lahusti - 75rÜ 10tk; 75rÜ 1tk; 75rÜ 5tk
meriofert set süstelahuse pulber ja lahusti
ibsa farmaceutici italia s.r.l. - menopausaalne humaangonadotropiin - süstelahuse pulber ja lahusti - 150rÜ 5tk; 150rÜ 1tk
meriofert set süstelahuse pulber ja lahusti
ibsa farmaceutici italia s.r.l. - menopausaalne humaangonadotropiin - süstelahuse pulber ja lahusti - 900rÜ 1tk
lubion süstelahus süstlis
ibsa farmaceutici italia s.r.l. - progesteroon - süstelahus süstlis - 25mg 7tk; 25mg 14tk
meriofert süstelahuse pulber ja lahusti
ibsa farmaceutici italia s.r.l. - menopausaalne humaangonadotropiin - süstelahuse pulber ja lahusti - 150rÜ 10tk; 150rÜ 1tk; 150rÜ 5tk
meriofert süstelahuse pulber ja lahusti
ibsa farmaceutici italia s.r.l. - menopausaalne humaangonadotropiin - süstelahuse pulber ja lahusti - 75rÜ 10tk; 75rÜ 5tk; 75rÜ 1tk
dentocaine 40mg/0,005 mg/ml süstelahus
inibsa dental s.l. - artikaiin+epinefriin (adrenaliin) - süstelahus - 40mg+0,005mg 1ml 1.8ml 50tk
dentocaine 40mg/0,01 mg/ml süstelahus
inibsa dental s.l. - artikaiin+epinefriin (adrenaliin) - süstelahus - 40mg+0,01mg 1ml 1.8ml 100tk; 40mg+0,01mg 1ml 1.8ml 50tk